Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Price Anomaly Detection Artificial Intelligence Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The price...
Read More -
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Smart Portable Ultrasound Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The smart portable ultrasound market...
Read More
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Military Logistics Artificial intelligence (AI) Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The military...
-
Alexandria Real Estate Equities, Inc. Securities Fraud Class Action Deadline January 26 – Investors with Losses Notified to Contact BFA Law
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Price Anomaly Detection Artificial Intelligence Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The price...
-
THE WOODLANDS, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) (“the Company” or “Howard Hughes”) announced today that the Company will release 2025 fourth quarter...
-
LEHI, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- New research published by SchoolAI, a comprehensive classroom AI platform, provides educators, school leaders, and policymakers with rare, large-scale...
-
Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Smart Portable Ultrasound Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The smart portable ultrasound market...
-
Fermi Inc. Securities Class Action Deadline March 6 – Investors with Losses Notified to Contact BFA Law
-
The collaboration between Microchip and NVIDIA helps deliver secure, tailored firmware solutions that address the complex needs of modern computing.
-
Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarterPreliminary ending 2025 cash and cash...
-
Combination of AT7687 and cagrilintide demonstrated enhanced weight loss effect in obese, insulin-resistant, pre-diabetic non-human primate (NHP) modelAdditional weight loss observed in combination...